How does miR-130a targeting of HOXA5 mechanistically regulate angiogenic processes in extracellular vesicles?

While HOXA5 was identified as a miR-130a target through gain-of-function experiments, the specific pathway by which this interaction controls angiogenesis remains unclear. This mechanistic gap limits understanding of how to optimize sEV therapeutic potential.

Gap type: unexplained_observation Source paper: miR-130a and Tgfβ Content in Extracellular Vesicles Derived from the Serum of Subjects at High Cardiovascular Risk Predicts their In-Vivo Angiogenic Potential. (2020, Scientific reports, PMID:31959759)